Agilent Technologies, Inc. (NYSE:A) Shares Bought by Lake Street Advisors Group LLC

Lake Street Advisors Group LLC boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 7.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,529 shares of the medical research company’s stock after purchasing an additional 234 shares during the period. Lake Street Advisors Group LLC’s holdings in Agilent Technologies were worth $475,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in A. IFP Advisors Inc increased its stake in Agilent Technologies by 17.7% in the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock worth $62,000 after purchasing an additional 69 shares in the last quarter. Brown Brothers Harriman & Co. increased its position in shares of Agilent Technologies by 13.5% in the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after acquiring an additional 77 shares in the last quarter. Rothschild Investment LLC raised its holdings in shares of Agilent Technologies by 19.2% during the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock valued at $66,000 after acquiring an additional 79 shares during the period. Rovin Capital UT ADV lifted its position in shares of Agilent Technologies by 1.6% in the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after acquiring an additional 81 shares in the last quarter. Finally, Integrated Advisors Network LLC boosted its stake in Agilent Technologies by 2.5% in the 3rd quarter. Integrated Advisors Network LLC now owns 3,582 shares of the medical research company’s stock worth $532,000 after purchasing an additional 86 shares during the period.

Agilent Technologies Trading Down 5.5 %

Shares of NYSE:A opened at $127.07 on Friday. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $36.25 billion, a PE ratio of 28.75, a P/E/G ratio of 3.63 and a beta of 1.07. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The firm has a fifty day moving average price of $140.78 and a 200 day moving average price of $139.20.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is 22.40%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Sanford C. Bernstein cut their target price on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Bank of America dropped their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Wells Fargo & Company decreased their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Robert W. Baird dropped their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday. Finally, Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $135.00 to $145.00 in a report on Monday, February 10th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $146.15.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.